Mirdametinib (PD0325901) Liposomes, Formulation U6-2
3195 EUR
In Stock
quantity
Produktdetaljer
Katalognummer: 1142 - DLL-0008-1D-100MG
Produktkategori: Företag och industri > Vetenskap och laboratorium
Gentaur
Storlek: 10 mL
Parameters
| Additional information | 292 mM sucrose, 0.5% DPBS (1X) |
|---|
DLL-0008-1A-100MG
Mirdametinib (PD0325901) Liposomes, Formulation U6-2
PEGylated liposomes containing MEK inhibitor Mirdametinib (PD0325901). Mirdametinib (PD0325901) is a selective and non ATP-competitive MEK inhibitor with an IC50 of 0.33 nM (cell-free assays). The liposomes are PEGylated for optimal in vivo performance. For preclinical research use only.
2995 €
DLL-0008-1A-10MG
Mirdametinib (PD0325901) Liposomes, Formulation U6-2
PEGylated liposomes containing MEK inhibitor Mirdametinib (PD0325901). Mirdametinib (PD0325901) is a selective and non ATP-competitive MEK inhibitor with an IC50 of 0.33 nM (cell-free assays). The liposomes are PEGylated for optimal in vivo performance. For preclinical research use only.
595 €
DLL-0008-1A-25MG
Mirdametinib (PD0325901) Liposomes, Formulation U6-2
PEGylated liposomes containing MEK inhibitor Mirdametinib (PD0325901). Mirdametinib (PD0325901) is a selective and non ATP-competitive MEK inhibitor with an IC50 of 0.33 nM (cell-free assays). The liposomes are PEGylated for optimal in vivo performance. For preclinical research use only.
995 €
Håll dig uppdaterad! Visa tidigare publikationer
By: Author , 2 Comment
Pneumokocker – vad är det som angriper våra barn?
30 August 2025
By: Author , 2 Comment
Anaplasmos hos hundar och katter – allt du behöver veta
23 August 2025
By: Author , 2 Comment
Solbränna – hur leker man säkert i solen?
16 August 2025
By: Author , 2 Comment
Stroke – viktig information
8 August 2025